2020 annual financial data

Bolt Biotherapeutics 2020 Net margin

Bolt Biotherapeutics 2020 net margin with verified reported values.

Direct answer

Net margin was -26,289.18%.

Operating income was -49,182,000 USD and net income was -60,728,000 USD.
Operating cash flow was -47,308,000 USD.

Get free Bolt Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
231,000 USD
Operating income
-49,182,000 USD
Net income
-60,728,000 USD
Operating cash flow
-47,308,000 USD